| View |
|
DRP-9660
|
Zoledronic Acid
|
Zdonate
|
5mg/100mL
|
Solution for Injection (I.V. Infusion)
|
Bisphosphonate
|
Gland Pharma Limited
|
India
|
Initial
|
27 April 2021
|
27 April 2026
|
| View |
|
DRP-9661
|
Moxifloxacin (as hydrochloride)
|
Lumemox
|
5 mg/mL (0.5% w/v)
|
Sterile Ophthalmic Solution (Eye Drops)
|
Anti-infective (Fluoroquinolone)
|
Axa Parenterals Limited
|
India
|
Initial (Reconstruction)
|
12 August 2024
|
23 April 2026
|
| View |
|
DRP-9662
|
Ascorbic Acid + Zinc
|
PAKZNC
|
500mg (equivalent to 562.5mg Sodium Ascorbate) / 40mg (equivalent to 109.8mg Zinc Sulfate Monohydrate)
|
Capsule
|
Vitamin/ Mineral
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial (OTC)
|
23 April 2021
|
23 April 2026
|
| View |
|
DRP-9663
|
Cholecalciferol (Vitamin D3) + Minerals
|
Calcidoc Plus
|
Each film-coated tablet contains: Cholecalciferol (Vitamin D3), USP-500IU Calcium (equivalent to 1498.38mg Calcium Carbonate), USP-600mg Magnesium (equivalent to 82.92mg Magnesium Oxide), USP-50mg
Zinc (equivalent to 9.34mg Zinc Oxide), USP-7.5mg Manganese (equivalent to 5.54mg Manganese Sulfate Monohydrate), USP-1.8mg Copper (equivalent to 3.93mg Copper Sulfate Pentahydrate), USP-1mg
|
Film Coated Tablet
|
Vitamin / Minerals
|
Phil. United Pharma Corp.(PUPC)
|
Philippines
|
Initial (OTC)
|
27 April 2021
|
27 April 2026
|
| View |
|
DRP-9664
|
Piperacillin (as Sodium) + Tazobactam (as Sodium)
|
Pitanic
|
4 g/500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
Inject Care Parenterals Pvt. Ltd.
|
India
|
Initial
|
27 April 2021
|
27 April 2026
|
| View |
|
DRP-9664-01
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Ureitaz
|
4 g/500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin/Beta-lactamase Inhibitor)
|
Inject Care Parenterals Pvt. Ltd
|
India
|
CLIDP Conversion
|
12 November 2023
|
27 April 2026
|
| View |
|
DRP-9665
|
Ceftazidime (as pentahydrate)
|
Ceftakon
|
1 g
|
Sterile Powder for Injection (I.M./I.V.)
|
-
|
Sance Laboratories Pvt. Ltd.
|
India
|
-
|
15 July 2021
|
15 July 2026
|
| View |
|
DRP-9666
|
Olanzapine
|
Olan ODT
|
10 mg
|
Orodispersible Tablet
|
Antipsychotic
|
Micro Labs Limited
|
India
|
Initial
|
27 April 2021
|
27 April 2026
|
| View |
|
DRP-9667
|
Clonidine Hydrochloride
|
None
|
150mcg
|
Tablet
|
Antihypertensive (Imidazole receptor agonist)
|
AM-Europharma Corporation
|
Philippines
|
Initial
|
27 April 2021
|
27 April 2026
|
| View |
|
DRP-9668
|
Ceftriaxone (As Sodium)
|
Synoxon
|
1 g
|
Powder For Injection(IM/IV)
|
Antibacterial (Cephalosporin)
|
NCPC Hebei Huamin Pharmaceutical Company
Limited
|
China
|
Initial
|
27 April 2021
|
27 April 2026
|
| View |
|
DRP-9668-01
|
Ceftriaxone (as sodium)
|
Q Taxone
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
NCPC Hebei Huamin Pharmaceutical Company Limited
|
China
|
CLIDP Conversion
|
11 October 2023
|
27 April 2026
|
| View |
|
DRP-9668-02
|
Ceftriaxone (as sodium)
|
Gotrax
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
NCPC Hebei Huamin Pharmaceutical Company Limited
|
China
|
CLIDP Conversion
|
19 February 2024
|
27 April 2026
|
| View |
|
DRP-9669
|
Etoricoxib
|
None
|
120mg
|
Film-Coated Tablet
|
-
|
Mankind Pharma Limited (Unit II)
|
India
|
Initial
|
28 April 2021
|
28 April 2026
|
| View |
|
DRP-9670
|
Etoricoxib
|
None
|
90mg
|
Film-Coated Tablet
|
-
|
Mankind Pharma Limited (Unit II)
|
India
|
Initial
|
28 April 2021
|
28 April 2026
|
| View |
|
DRP-9671
|
Etoricoxib
|
None
|
60mg
|
Film-Coated Tablet
|
-
|
Mankind Pharma Limited (Unit II)
|
India
|
Initial
|
28 April 2021
|
28 April 2026
|
| View |
|
DRP-9672
|
Valsartan
|
None
|
160 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
United International Pharma Co., Ltd.
|
Vietnam
|
Initial
|
28 April 2021
|
28 April 2026
|
| View |
|
DRP-9673
|
Valsartan
|
None
|
80 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
United International Pharma Co., Ltd.
|
Vietnam
|
Initial
|
28 April 2021
|
28 April 2026
|
| View |
|
DRP-9674
|
Ascorbic Acid
|
None
|
500mg (equivalent to 562.43 mg Sodium Ascorbate) /10mg (equivalent to 70 mg Zinc Gluconate)
|
Capsule
|
Vitamin/Mineral
|
Philmed Laboratories, Inc.
|
Philippines
|
Initial (OTC)(PCPR)
|
27 April 2021
|
27 April 2026
|
| View |
|
DRP-9674-01
|
Ascorbic acid + Zinc
|
Renzinc
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate) / 10mg (equivalent to 70 mg Zinc Gluconate)
|
Capsule
|
-
|
Philmed Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
11 November 2022
|
27 April 2026
|
| View |
|
DRP-9675
|
Cetirizine Hydrochloride + Phenylephrine Hydrochloride
|
None
|
5 mg / 10 mg
|
Film Coated Tablet
|
Antihistamine/Nasal Decongestant
|
Phil. United Pharma Corp.
|
Philippines
|
Initial[OTC][PCPR ]
|
29 April 2021
|
29 April 2026
|